Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Cash from Operations (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Cash from Operations readings, the most recent being 8026000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations fell 90.78% to 8026000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 15970000.0, a 57.03% increase, with the full-year FY2025 number at 15970000.0, up 57.03% from a year prior.
  • Cash from Operations hit 8026000.0 in Q4 2025 for Treace Medical Concepts, up from 9092000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 4198000.0 in Q1 2025 to a low of 17259000.0 in Q1 2023.
  • Median Cash from Operations over the past 5 years was 7365500.0 (2022), compared with a mean of 6777650.0.
  • Biggest five-year swings in Cash from Operations: tumbled 1710.25% in 2022 and later skyrocketed 158.14% in 2025.
  • Treace Medical Concepts' Cash from Operations stood at 3793000.0 in 2021, then plummeted by 41.26% to 5358000.0 in 2022, then surged by 109.93% to 532000.0 in 2023, then tumbled by 890.79% to 4207000.0 in 2024, then tumbled by 90.78% to 8026000.0 in 2025.
  • The last three reported values for Cash from Operations were 8026000.0 (Q4 2025), 9092000.0 (Q3 2025), and 3050000.0 (Q2 2025) per Business Quant data.